CoChat

Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom

Arias, Ana Silvia, Rucavado, Alexandra, Gutiérrez, José María · 2017 · Toxicon
Cited by 90

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.toxicon.2017.04.001

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 40

  1. Abubakar, 2010, Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria, PLoS Negl. Trop. Dis., 4, e767, 10.1371/journal.pntd.0000767 · DOI
  2. Angulo, 2003, Inhibitory effect of fucoidan on the activities of crotaline snake venom myotoxic phospholipases A2, Biochem. Pharmacol., 66, 1993, 10.1016/S0006-2952(03)00579-3 · DOI
  3. Bastos, 2016, Natural inhibitors of snake venom metalloendopeptidases: history and current challenges, Toxins, 8, 250, 10.3390/toxins8090250 · DOI
  4. Bode, 1993, Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins', FEBS Lett., 331, 134, 10.1016/0014-5793(93)80312-I · DOI · Paper page
  5. Bottomley, 1998, Matrix metalloproteinase inhibitors in arthritis, J. Enzyme Inhib., 13, 79, 10.3109/14756369809035829 · DOI
  6. Chacón, 2015, The lethality test used for estimating the potency of antivenoms against Bothrops asper snake venom: pathophysiological mechanisms, prophylactic analgesia, and a surrogate in vitro assay, Toxicon, 93, 41, 10.1016/j.toxicon.2014.11.223 · DOI
  7. Chippaux, 1998, Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon, Trans. R. Soc. Trop. Med. Hyg., 92, 657, 10.1016/S0035-9203(98)90802-1 · doi:10.1016/s0035-9203(98)90802-1
  8. Escalante, 2000, Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper, Biochem. Pharmacol., 60, 269, 10.1016/S0006-2952(00)00302-6 · DOI
  9. Escalante, 2003, Pulmonary hemorrhage induced by jararhagin, a metalloproteinase from Bothrops jararaca snake venom, Toxicol. Appl. Pharmacol., 193, 17, 10.1016/S0041-008X(03)00337-5 · DOI
  10. Escalante, 2011, Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases, J. Proteom., 74, 1781, 10.1016/j.jprot.2011.03.026 · DOI · Paper page
  11. Flipo, 2009, Hydroxamates: relationships between structure and plasma stability, J. Med. Chem., 52, 6790, 10.1021/jm900648x · DOI
  12. Gené, 1989, Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom, Toxicon, 27, 841, 10.1016/0041-0101(89)90096-2 · DOI
  13. Gutiérrez, 2012, Improving antivenom availability and accessibility: science, technology, and beyond, Toxicon, 60, 676, 10.1016/j.toxicon.2012.02.008 · DOI · Paper page
  14. Gutiérrez, 1980, Mionecrosis, hemorragia y edema inducidos por el veneno de Bothrops asper en ratón blanco, Toxicon, 18, 603, 10.1016/0041-0101(80)90087-2 · DOI
  15. Gutiérrez, 2014, A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming, Bull. World Health Organ., 92, 526, 10.2471/BLT.13.132431 · DOI
  16. Gutiérrez, 1985, Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom, Toxicon, 23, 887, 10.1016/0041-0101(85)90380-0 · DOI · Paper page
  17. Gutiérrez, 2007, Trends in snakebite envenomation therapy: scientific, technological and public health considerations, Curr. Pharm. Des., 13, 2935, 10.2174/138161207782023784 · DOI · Paper page
  18. Gutiérrez, 2005, Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage, Toxicon, 45, 997, 10.1016/j.toxicon.2005.02.029 · DOI · Paper page
  19. Gutiérrez, 2008, Snake venomics of the Lesser Antillean pit vipers Bothrops caribbaeus and Bothrops lanceolatus: correlation with toxicological activities and immunoreactivity of a heterologous antivenom, J. Proteome Res., 7, 4396, 10.1021/pr8003826 · DOI
  20. Gutiérrez, 2010, Snakebite envenoming from a global perspective: towards an integrated approach, Toxicon, 56, 1223, 10.1016/j.toxicon.2009.11.020 · DOI · Paper page
  21. Habib, 2013, Public health aspects of snakebite care in West Africa: perspectives from Nigeria, J. Venom. Anim. Toxins Incl. Trop. Dis., 19, 27, 10.1186/1678-9199-19-27 · doi:10.1186/1678-9199-19-27
  22. Howes, 2007, Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators, Toxicon, 49, 734, 10.1016/j.toxicon.2006.11.020 · DOI
  23. Howes, 2003, The purification and partial characterisation of two novel metalloproteinases from the venom of the West African carpet viper, Echis ocellatus, Toxicon, 42, 21, 10.1016/S0041-0101(03)00096-5 · doi:10.1016/s0041-0101(03)00096-5
  24. Kini, 2005, The intriguing world of prothrombin activators from snake venom, Toxicon, 45, 1133, 10.1016/j.toxicon.2005.02.019 · DOI
  25. Kondo, 1960, Studies on the quantitative method for the determination of hemorrhagic activity of Habu snake venom, Jpn. J. Med. Sci. Biol., 13, 43, 10.7883/yoken1952.13.43 · DOI · Paper page
  26. Kornalik, 1975, Prothrombin activation induced by Ecarin - a prothrombin converting enzyme from Echis carinatus venom, Thromb. Res., 6, 57, 10.1016/0049-3848(75)90150-4 · DOI · Paper page
  27. Laustsen, 2016, From fangs to Pharmacology: the future of snakebite envenoming therapy, Curr. Pharm. Des., 22, 5270, 10.2174/1381612822666160623073438 · DOI · Paper page
  28. Lewin, 2016, Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation, Toxins, 8, 248, 10.3390/toxins8090248 · DOI · Paper page
  29. Murakami, 2005, Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin, J. Mol. Biol., 350, 416, 10.1016/j.jmb.2005.04.072 · DOI
  30. Nishida, 1995, cDNA cloning and deduced amino acid sequence of prothrombin activator (ecarin) from Kenyan Echis carinatus venom, Biochemistry, 34, 1771, 10.1021/bi00005a034 · DOI
  31. Ownby, 1984, A new method for quantitating hemorrhage induced by rattlesnake venoms: ability of polyvalent antivenom to neutralize hemorrhagic activity, Toxicon, 22, 227, 10.1016/0041-0101(84)90023-0 · doi:10.1016/0041-0101(84)90023-0
  32. Rao, 2005, Recent developments in the design of specific matrix metalloproteinase inhibitors aided by structural and computational studies, Curr. Pharm. Des., 11, 295, 10.2174/1381612053382115 · DOI · Paper page
  33. Rucavado, 2000, Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA, Am. J. Trop. Med. Hyg., 63, 313, 10.4269/ajtmh.2000.63.313 · DOI · Paper page
  34. Soares, 2005, Medicinal plants with inhibitory properties against snake venoms, Curr. Med. Chem., 12, 2625, 10.2174/092986705774370655 · DOI · Paper page
  35. Theakston, 1983, Development of simple standard assay procedures for the characterization of snake venom, Bull. World Health Organ., 61, 949
  36. Wagstaff, 2009, Combined snake venomics and venom gland transcriptomic analysis of the ocellated carpet viper, Echis ocellatus, J. Proteom., 71, 609, 10.1016/j.jprot.2008.10.003 · DOI
  37. Wang, 2004, A novel P-I class metalloproteinase with broad substrate-cleaving activity, agkislysin, from Agkistrodon acutus venom, Biochem. Biophys. Res. Commun., 324, 224, 10.1016/j.bbrc.2004.09.031 · doi:10.1016/j.bbrc.2004.09.031
  38. Warrell, 1974, Bites by the saw-scaled or carpet viper (Echis carinatus): trial of two specific antivenoms, Br. Med. J., 4, 437, 10.1136/bmj.4.5942.437 · DOI
  39. Yamada, 1997, Purification and characterization of a Ca2+-dependent prothrombin activator, multactivase, from the venom of Echis multisquamatus, J. Biochem., 122, 991, 10.1093/oxfordjournals.jbchem.a021862 · doi:10.1093/oxfordjournals.jbchem.a021862
  40. Yamada, 1996, Isolation and characterization of carinactivase, a novel prothrombin activator in Echis carinatus venom with a unique catalytic mechanism, J. Biol. Chem., 271, 5200, 10.1074/jbc.271.9.5200 · DOI

Cited by

See all 90

Metadata

Authors
Arias, A. S., Rucavado, A., & Gutiérrez, J. M.
Venue
Toxicon
Publisher
Elsevier BV
Published
2017-06
Volume
132
Pages
40-49
ISSN
0041-0101
Cited by
90
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
Universidad de Costa Rica (741-B5-285)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.